Penumbra Total Assets 2014-2022 | PEN

Penumbra total assets from 2014 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Penumbra total assets for the quarter ending June 30, 2022 were $1.328B, a 45.89% increase year-over-year.
  • Penumbra total assets for 2021 were $1.244B, a 51.19% increase from 2020.
  • Penumbra total assets for 2020 were $0.823B, a 23.59% increase from 2019.
  • Penumbra total assets for 2019 were $0.666B, a 29.3% increase from 2018.
Penumbra Annual Total Assets
(Millions of US $)
2021 $1,244
2020 $823
2019 $666
2018 $515
2017 $477
2016 $308
2015 $264
2014 $121
2013 $71
Penumbra Quarterly Total Assets
(Millions of US $)
2022-06-30 $1,328
2022-03-31 $1,302
2021-12-31 $1,244
2021-09-30 $973
2021-06-30 $910
2021-03-31 $841
2020-12-31 $823
2020-09-30 $810
2020-06-30 $780
2020-03-31 $664
2019-12-31 $666
2019-09-30 $614
2019-06-30 $585
2019-03-31 $569
2018-12-31 $515
2018-09-30 $501
2018-06-30 $499
2018-03-31 $490
2017-12-31 $477
2017-09-30 $459
2017-06-30 $417
2017-03-31 $418
2016-12-31 $308
2016-09-30 $297
2016-06-30 $284
2016-03-31 $275
2015-12-31 $264
2015-09-30 $259
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2013-12-31 $71
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.042B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.578B 23.18
Edwards Lifesciences (EW) United States $62.887B 44.49
Alcon (ALC) Switzerland $36.987B 31.32
STERIS (STE) Ireland $20.913B 25.96
Teleflex (TFX) United States $11.693B 18.63
Fresenius Medical Care AG KGaA (FMS) Germany $10.936B 10.09
Globus Medical (GMED) United States $6.491B 32.38
Glaukos (GKOS) United States $2.370B 0.00
Integer Holdings (ITGR) United States $2.345B 18.34
Nevro (NVRO) United States $1.688B 0.00
Paragon 28 (FNA) United States $1.486B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.365B 20.90
Artivion (AORT) United States $0.860B 82.00